MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-08-0027983
Solivare Pharma Private Limited
Solivare Pharma Private Limited - chemicals in New Delhi, Delhi, India. Directors, charges & compliance details.
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Delhi
ROC office
About Solivare Pharma Private Limited
Data last updated:
Solivare Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 March 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2022PTC394585.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Atul Kumar and Sujit Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 35 Basement Block C South Extn II, New Delhi, Delhi, India – 110049.
Solivare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0027983). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239DL2022PTC394585
Registration Number 394585
Incorporation Date 03 March 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0027983
Recognitions & Rankings of Solivare Pharma
Contact details
Solivare Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressPlot No – 35 Basement Block C South Extn II, New Delhi, Delhi, India – 110049
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Solivare Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Solivare Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Solivare Pharma Private Limited, buy the company report.
Board of directors of Solivare Pharma Private Limited
Solivare Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Kumar Also directs: Mata Jagmato Devi Engicon Private Limited | Additional Director | 27 Apr 2023 | 3 Years 6 Months | Current |
| Sujit Kumar Singh | Additional Director | 20 May 2025 | 1 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Solivare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solivare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Solivare Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Solivare Pharma Private Limited has 6 board changes on record since 2023: 3 appointments and 3 cessations. The latest: Sujit Kumar Singh was appointed as Additional Director on 20 May 2025.
AGM
Solivare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Sujit Kumar Singh was appointed as Additional Director.
Ceased
Vicky Kumar Sah ceased to be Additional Director.
Filing
Solivare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Nibha Thakur ceased to be Director.
Ceased
Sujeet Kumar Jha ceased to be Director.
Appointed
Atul Kumar was appointed as Additional Director.
Appointed
Vicky Kumar Sah was appointed as Additional Director.
Incorporation
03 Mar 2022
Solivare Pharma Private Limited was registered on 03 Mar 2022 with Roc Delhi I & aged 4 years 8 months as per MCA records.
Frequently asked questions
Solivare Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 March 2022 (4+ years old) and is registered under CIN U24239DL2022PTC394585.
Solivare Pharma has 2 current directors:
- Atul Kumar - Additional Director
- Sujit Kumar Singh - Additional Director
The latest financial statements of Solivare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Solivare Pharma is U24239DL2022PTC394585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solivare Pharma was incorporated on 03 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Sujit Kumar Singh was appointed as Additional Director on 20 May 2025. Vicky Kumar Sah ceased to be Additional Director on 20 May 2025. Nibha Thakur ceased to be Director on 12 Aug 2023. Solivare Pharma has 6 board changes on record in total.
Yes, Solivare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0027983).
The registered office of Solivare Pharma is at Plot No – 35 Basement Block C South Extn II, New Delhi, Delhi, India – 110049.
Solivare Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Solivare Pharma is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages